跳至主要内容
临床试验/NCT05108597
NCT05108597已完成3 期

Effect of Rectal Misoprostol in Reducing Intra-operative Blood Loss During Myomectomy A Randomized Control Trial

Pak Emirates Military Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2019年3月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
200
试验地点
1
主要终点
Intraoperative blood loss

研究概览

简要总结

A total of 200 women for elective abdominal myomectomy were randomly allocated into two groups.

100 women in experimental group were administered 400ug Misoprostol (2 tablets of Prosotec®) through the rectal route prior to surgery and 100 were in control group, in which no drug was administered.

详细描述

After getting approval from hospital's ethical committee, patients eligible for the study were recruited in the study according to the selection criteria. Before surgery, after taking informed written consent, patient's detailed history including demographics, parity & BMI was recorded. Uterine size was assessed by bimanual pelvic examination. Patients undergoing myomectomy were randomly divided into 2 groups using lottery method. In experimental group Misoprostol 400ug was administered per rectally prior to surgery. In control group, no drug was administered.

The surgical procedural elements, the surgeon or surgeons performing the procedure and the use of antibiotics as well as anesthetic agents was standardized to remove any bias. Intraoperative blood loss was recorded by a single trained doctor and calculated using visual scale for the abdominal sponges and chest swabs/gauzes used during surgery and blood collected in suction bottle.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Outcomes Assessor)

盲法说明

There will be a single trained person who calculated the intra-operative blood loss and was blinded to the randomization of the patients and the use of medication.

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • ASA physical status class I-II
  • Intramural or subserosal fibroids - diagnosed on ultrasound
  • Candidates for elective abdominal myomectomy

排除标准

  • Pre-operative Hemoglobin < 10 g/dl
  • Patient who received Danazol or GnRH analogues before surgery
  • No other systemic or metabolic disease

研究组 & 干预措施

Misoprostol (Study Group)

Experimental

In study group, 400ug misoprostol will be administered through rectal route, 1 hour before surgery.

干预措施: Misoprostol (Drug)

结局指标

主要结局

Intraoperative blood loss

时间窗: During the surgical procedure

Intraoperative blood loss will be recorded by a trained doctor and calculated using visual scale for the abdominal sponges and chest swabs/gauzes used during surgery and blood collected in suction bottle.

次要结局

未报告次要终点

研究者

发起方
Pak Emirates Military Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Salma Nisar

Resident OBGYN

Pak Emirates Military Hospital

研究点 (1)

Loading locations...

相似试验